
Celltrion Signs ‘Incubation’ Agreement on New Drugs for Atherosclerosis
The Pharma Letter website reported that South Korean drugmaker Celltrion has signed an ‘incubation’ agreement with Emory University in Atlanta, to support the research and development of new drug candidates for atherosclerosis. An ‘incubation’ agreement is one of the open innovation measures by which a company provides its internal resources
Comments Off on Celltrion Signs ‘Incubation’ Agreement on New Drugs for Atherosclerosis • Read this story »
More Articles

Drug Consortium Offers $50M for Collective Research
MarketWatch website reports that the Takeda Pharmaceutical Company has joined the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to market faster. Takeda’s contribution raises the total to $50 million in support of the SGC